A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
两种引起狗感染性休克的大肠杆菌菌株的比较
基本信息
- 批准号:6161407
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Summary of Work: While live bacteria commonly cause infection, the
relative role of bacterial toxins versus live bacteria to produce
morbidity and mortality is not known. If bacterial toxins are important
factors, therapies directed at these toxins may be required. Even if no
bacteria remain alive or grow, these preformed toxins may be important
in determining morbidity and mortality. Therapies directed at these
toxins may be important additions to antibiotic therapy.
Using two strains of Escherichia coli, a nonvirulent E. coli strain
(O86;H8) and a virulent E. coli strain (O6;Hl;K2), in the canine model,
we designed a study to determine whether organism virulence factors or
bacterial toxins were more important in producing septic shock. Measures
of hemodynamic shock, blood cultures, endotoxin levels, and survival
were done serially with both organisms live, both organisms killed, and
with purified endotoxin from these organisms. Preliminary results from
these studies have been presented to the American Federation of Clinical
Research and the Society of Critical Care Medicine. The results
suggested that virulence factors are much more important than preformed
endotoxins for the development of endotoxemia.
To further address this issue, we are collaborating with Tom Russo of
LCI, MAID, and more recently the University of Buffalo, to examine the
role of endotoxin as a virulence factor within the same of E. coli. We
are using a gene disruption technique to produce an E. Coli strain with
a deficiency in endotoxin O type side chains (another virulence factor).
This will further explore the relative role of endotoxin in septic
shock. Much work is presently being done to target this pathogen in
human septic shock. There has been much interest in these results
because the determination of the factors that produce morbidity in
infection will guide trials for future therapies for children and adults
with septic shock.
工作总结:虽然活细菌通常会导致感染,但
细菌毒素与活细菌产生的相对作用
发病率和死亡率尚不清楚。如果细菌毒素很重要
因素,针对这些毒素的治疗可能是必需的。即使不是
细菌保持存活或生长,这些预先形成的毒素可能是重要的
在确定发病率和死亡率方面。针对这些问题的治疗
毒素可能是抗生素治疗的重要补充。
使用两株大肠杆菌,一种无毒力的大肠杆菌菌株
(O86;H8)和一株强毒力大肠杆菌(O6;H1;K2),在犬模型中,
我们设计了一项研究,以确定生物体毒力因素或
细菌毒素在感染性休克的发生中起更重要的作用。措施
血流动力学休克、血培养、内毒素水平和存活率
都是连续进行的,这两种生物都活着,两种生物都被杀死了,以及
从这些生物中提纯的内毒素。初步结果来自
这些研究已经提交给美国临床联合会。
研究和重症护理医学学会。结果是
表明毒力因素比预制的更重要
内毒素与内毒素血症的发展
为了进一步解决这个问题,我们正在与汤姆·鲁索合作
LCI,女佣,最近在布法罗大学,检查
内毒素在大肠杆菌中作为毒力因子的作用。我们
正在使用基因破坏技术来生产一种具有
内毒素O型侧链缺陷(另一个致病因素)。
这将进一步探讨内毒素在脓毒症中的相对作用。
令人震惊。目前正在做大量的工作来针对这种病原体
人类败血症休克。人们对这些结果很感兴趣
因为确定在中国引起发病率的因素
感染将指导儿童和成人未来治疗的试验
感染性休克。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
C NATANSON其他文献
C NATANSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('C NATANSON', 18)}}的其他基金
USE OF A SELECTIVE BRADYKININ ANTAGONIST IN A CANINE MODEL OF SEPTIC SHOCK
选择性缓激肽拮抗剂在犬感染性休克模型中的应用
- 批准号:
5201091 - 财政年份:
- 资助金额:
-- - 项目类别:
NITRIC OXIDE SYNTHASE INHIBITORS IN VIVO TNF-INDUCED MYOCARDIAL DEPRESSION
一氧化氮合酶抑制剂体内 TNF 诱导的心肌抑制
- 批准号:
3752179 - 财政年份:
- 资助金额:
-- - 项目类别:
MYOCARDIAL METABOLISM IN A CANINE MODEL OF HUMAN BACTERIAL SEPSIS
人类细菌性脓毒症犬模型的心肌代谢
- 批准号:
3774436 - 财政年份:
- 资助金额:
-- - 项目类别:
A COMPARISON OF STRAINS OF E. COLI TO PRODUCE SEPTIC SHOCK IN DOGS
引起狗败血性休克的大肠杆菌菌株比较
- 批准号:
3853021 - 财政年份:
- 资助金额:
-- - 项目类别:
CONTROLLED TRIAL OF TYROSINE KINASE INHIBITORS IN CANINE MODEL OF SEPTIC SHOCK
酪氨酸激酶抑制剂在犬感染性休克模型中的对照试验
- 批准号:
2456661 - 财政年份:
- 资助金额:
-- - 项目类别:
A COMPARISON OF TWO STRAINS OF E COLI TO PRODUCE SEPTIC SHOCK IN DOGS
两种引起狗感染性休克的大肠杆菌菌株的比较
- 批准号:
5201066 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
9884089 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
10438532 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
10553173 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
9275348 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
8965936 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Molecular Pathogenesis of Enterotoxigenic Escherichia coli Infections
产肠毒素大肠杆菌感染的分子发病机制
- 批准号:
8245631 - 财政年份:2012
- 资助金额:
-- - 项目类别:
Host, environmental, and bacterial factors associated with animal pathogenic and zoonotic Escherichia coli infections
与动物致病性和人畜共患大肠杆菌感染相关的宿主、环境和细菌因素
- 批准号:
2294-2010 - 财政年份:2010
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2009
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2008
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual
Host and bacterial factors in the pathogenesis of attaching and effacing escherichia coli infections in animals
动物附着和消除大肠杆菌感染发病机制中的宿主和细菌因素
- 批准号:
2294-2005 - 财政年份:2007
- 资助金额:
-- - 项目类别:
Discovery Grants Program - Individual